The characteristics at initial diagnosis of this cohort was very similar to that observed in this study (median age of 57 years, secondary AML in 11%, extramedullary disease in 41%, IDH mutations in 11%, median WBC of 51 × 109/L and NPM1 co-mutations in 65%). This evidence concerns the gene NPM1 and acute myeloid leukemia.